Risk of recurrence of BE after successful endoscopic therapy

Rajesh Krishnamoorthi, MD, from the Division of Gastroenterology and Hepatology, Department of Internal Medicine, at Mayo Clinic in Rochester, Minnesota, USA discusses this systematic review and meta-analysis "Risk of recurrence of Barrett’s esophagus after successful endoscopic therapy." Endoscopic therapy is currently the treatment of choice for Barrett’s esophagus (BE) related dysplasia and mucosal adenocarcinoma. While …

Continue reading Risk of recurrence of BE after successful endoscopic therapy